Who owns TERNS PHARMACEUTICALS INC?
- Ticker: TERN
- CUSIP Number: 880881107
Tip: Access positions for across all investors
Analyze quarterly positions in Terns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Terns Pharmaceuticals stock
Who bought or sold TERNS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 7.6M | $50M | 0% | Mar 2024 |
|
| Vivo Capital | 6.7M | $44M | 0% | Mar 2024 |
|
| Millennium Management | 3.4M | $23M | 69% | Mar 2024 |
|
| VR Adviser | 3.4M | $22M | -24% | Mar 2024 |
|
| BlackRock | 3.3M | $22M | 5% | Mar 2024 |
|
| Citadel Advisors | 3.0M | $20M | 4529% | Mar 2024 |
|
| FMR | 2.8M | $18M | -46% | Mar 2024 |
|
| Franklin Resources | 2.4M | $16M | 3% | Mar 2024 |
|
| Point72 Asset Management | 2.2M | $15M | 100% | Mar 2024 |
|
| Vanguard Group | 2.2M | $14M | 1% | Mar 2024 |
|
| Fairmount Funds Management | 2.0M | $13M | 0% | Mar 2024 |
|
| Henderson Group | 2.0M | $13M | 41% | Mar 2024 |
|
| Suvretta Capital Management | 1.4M | $8.9M | -77% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.3M | $8.6M | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 1.2M | $7.8M | 193% | Mar 2024 |
|
| Geode Capital Management | 866k | $5.7M | 10% | Mar 2024 |
|
| Adage Capital Partners GP | 850k | $5.6M | 750% | Mar 2024 |
|
| Decheng Capital | 714k | $4.6M | 100% | Dec 2023 |
|
| Russell Investments | 633k | $4.2M | 128% | Mar 2024 |
|
| Octagon Capital Advisors | 625k | $4.1M | 100% | Mar 2024 |
|
| Morgan Stanley | 587k | $3.8M | -41% | Mar 2024 |
|
| Jpmorgan Chase & Co | 422k | $2.8M | 93% | Mar 2024 |
|
| Northern Trust | 356k | $2.3M | 2% | Mar 2024 |
|
| Dimensional Fund Advisors | 340k | $2.2M | 337% | Mar 2024 |
|
| Monashee Investment Management | 300k | $2.0M | 100% | Mar 2024 |
|
| Barclays | 248k | $1.6M | 194% | Mar 2024 |
|
| Bridger Management | 247k | $1.6M | 100% | Mar 2024 |
|
| Exome Asset Management | 228k | $1.5M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 207k | $1.4M | 142% | Mar 2024 |
|
| Samsara BioCapital | 202k | $1.3M | 0% | Mar 2024 |
|
| Marshall Wace | 186k | $1.2M | 100% | Mar 2024 |
|
| Nuveen Asset Management | 160k | $1.0M | 34% | Mar 2024 |
|
| Citigroup | 158k | $1.0M | 2121% | Mar 2024 |
|
| Susquehanna International | 150k | $986k | 112% | Mar 2024 |
|
| HighVista Strategies | 148k | $972k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 115k | $752k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 113k | $739k | -6% | Mar 2024 |
|
| Ikarian Capital | 89k | $581k | -47% | Mar 2024 |
|
| Springbok Capital Management | 85k | $555k | 100% | Mar 2024 |
|
| Hrt Financial | 75k | $490k | 100% | Mar 2024 |
|
| Squarepoint Ops | 71k | $468k | 100% | Mar 2024 |
|
| UBS Group | 63k | $412k | -42% | Mar 2024 |
|
| Swiss National Bank | 61k | $400k | -10% | Mar 2024 |
|
| Rhumbline Advisers | 59k | $387k | 2% | Mar 2024 |
|
| ExodusPoint Capital Management | 55k | $359k | 100% | Mar 2024 |
|
| American Century Companies | 55k | $357k | 162% | Mar 2024 |
|
| Jane Street | 48k | $313k | -26% | Mar 2024 |
|
| Virtu Financial | 44k | $291k | 100% | Mar 2024 |
|
| Bank of America Corporation | 38k | $252k | -35% | Mar 2024 |
|
| Credit Suisse | 34k | $223k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 32k | $211k | -13% | Mar 2024 |
|
| Graham Capital Management | 30k | $198k | 100% | Mar 2024 |
|
| Legal & General Group | 28k | $181k | 0% | Mar 2024 |
|
| Alliancebernstein | 26k | $168k | 0% | Dec 2023 |
|
| Deerfield Management Company | 24k | $158k | 39% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 24k | $155k | 3% | Mar 2024 |
|
| MetLife Investment Advisors | 23k | $150k | 0% | Dec 2023 |
|
| American International | 21k | $138k | 0% | Dec 2023 |
|
| Dynamic Technology Lab Private | 21k | $139k | 30% | Mar 2024 |
|
| T. Rowe Price Associates | 21k | $136k | 12% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 18k | $117k | 0% | Mar 2024 |
|
| D. E. Shaw & Co | 18k | $117k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 18k | $115k | 0% | Mar 2024 |
|
| Engineers Gate Manager | 17k | $113k | 100% | Mar 2024 |
|
| Martingale Asset Management | 16k | $100k | 100% | Dec 2023 |
|
| Kennedy Capital Management | 16k | $102k | 100% | Mar 2024 |
|
| Boothbay Fund Management | 15k | $101k | -77% | Mar 2024 |
|
| Walleye Trading | 15k | $98k | 100% | Mar 2024 |
|
| LPL Financial | 14k | $94k | 100% | Mar 2024 |
|
| Ing Investment Management | 14k | $94k | -20% | Mar 2024 |
|
| Wells Fargo & Company | 14k | $92k | 17% | Mar 2024 |
|
| Virtus ETF Advisers | 13k | $88k | -6% | Mar 2024 |
|
| ProShare Advisors | 12k | $80k | 100% | Mar 2024 |
|
| China Universal Asset Management | 12k | $78k | 66% | Mar 2024 |
|
| Sawtooth Asset Management | 11k | $68k | 100% | Dec 2023 |
|
| Zurcher Kantonalbank | 7.8k | $51k | -17% | Mar 2024 |
|
| ADAR1 Capital Management | 5.0k | $33k | -62% | Mar 2024 |
|
| Royal Bank of Canada | 3.6k | $25k | -75% | Mar 2024 |
|
| Summit Investment Advisors | 3.5k | $23k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 2.4k | $16k | 0% | Dec 2023 |
|
| Quadrant Capital | 1.8k | $12k | 435% | Mar 2024 |
|
| Amalgamated Bank | 1.4k | $9.0k | -73% | Mar 2024 |
|
| Aquatic Capital Management | 1.4k | $9.2k | 100% | Mar 2024 |
|
| GAMMA Investing | 1.0k | $6.7k | 613% | Mar 2024 |
|
| Stone House Investment Management | 1.0k | $6.6k | 100% | Mar 2024 |
|
| Us Bancorp | 695.00 | $4.6k | 80% | Mar 2024 |
|
| Tower Research Capital | 619.00 | $4.1k | -41% | Mar 2024 |
|
| Cubist Systematic Strategies | 327.00 | $2.1k | 100% | Mar 2024 |
|
| Zrc Wealth Management | 225.00 | $1.5k | 100% | Mar 2024 |
|
| Parallel Advisors | 211.00 | $1.4k | 85% | Mar 2024 |
|
| Capital Advisors | 183.00 | $1.0k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 151.00 | $999.997500 | 0% | Mar 2024 |
|
| Atlantic Trust | 100.00 | $710.000000 | 100% | Mar 2024 |
|
| Signature | 99.00 | $649.004400 | -88% | Mar 2024 |
|
| Hanson McClain Advisors | 90.00 | $591.003000 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 44.00 | $289.000800 | 91% | Mar 2024 |
|
| Farther Finance Advisors | 28.00 | $198.998800 | 40% | Mar 2024 |
|
| Pnc Financial Services | 17.00 | $111.999400 | 112% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 9.00 | $59.000400 | 100% | Mar 2024 |
|
Who sold out of Terns Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Braidwell | Dec 2023 | 2.3M | $15M |
| Perceptive Advisors | Dec 2023 | 1.1M | $7.0M |
| Norges Bank Investment Management | Dec 2023 | 427k | $2.8M |
| ALPS Advisors | Sep 2023 | 45k | $227k |
| Parkman Healthcare Partners | Sep 2023 | 42k | $210k |
| Mirae Asset Global Investments | Dec 2023 | 41k | $264k |
| Belvedere Trading | Sep 2023 | 37k | $183k |
| XTX Topco | Sep 2023 | 33k | $166k |
| Trexquant Investment | Sep 2023 | 32k | $159k |
| Bridgeway Capital Management | Sep 2023 | 28k | $138k |
| Walleye Trading Advisors | Dec 2023 | 25k | $164k |
| Balyasny Asset Management | Dec 2023 | 14k | $90k |
| Florida State Board of Administration | Dec 2023 | 12k | $81k |
| Brevan Howard Capital Management | Dec 2023 | 11k | $70k |
| Bleakley Financial Group | Dec 2023 | 11k | $68k |
| AJOVista | Dec 2023 | 8.9k | $58k |
| Quantbot Technologies | Sep 2023 | 2.3k | $12k |
| Fortitude Family Office | Dec 2023 | 300.00 | $1.9k |
| Simplex Trading | Dec 2023 | 170.00 | $1.0k |
| ICA Group Wealth Management | Dec 2023 | 80.00 | $519.000000 |